Tests | Sensitivity (95% CI) | Specificity (CI)* | ||||
---|---|---|---|---|---|---|
| ||||||
1 to 7 d† | 8 to 14 d† | 15 to 21 d† | 22 to 35 d† | > 35 d† | ||
| ||||||
IgG | 30% (22 to 39) | 67% (58 to 74) | 88% (84 to 74) | 80% (72 to 86) | 87% (80 to 92) | 99% (98 to 100) |
IgM | 23% (15 to 34) | 58% (46 to 70) | 75% (64 to 84) | 68% (55 to 79) | 54% (38 to 69) | 99% (98 to 99) |
IgG/IgM‡ | 30% (21 to 41) | 72% (64 to 80) | 91% (87 to 94) | 96% (91 to 98) | 78% (66 to 86) | 99% (97 to 99) |
Total antibodies | 25% (10 to 50) | 84% (64 to 94) | 98% (90 to 100) | 70% (35 to 91) | 79% (50 to 93) | 99% (98 to 100) |
CI defined in Glossary.
Meta-analysis of 35 studies (8526 cases) across all time points.
Days after symptom onset.
Positive if either IgG or IgM is positive.